Bafna Pharmaceuticals Limited Asset Resilience Ratio

Latest as of September 2025: 1.07%

Bafna Pharmaceuticals Limited asset resilience ratio. Bafna Pharmaceuticals Limited (BAFNAPH) has an Asset Resilience Ratio of 1.07% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Bafna Pharmaceuticals Limited (BAFNAPH) liquidity interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

Rs17.13 Million

≈ $185.21K USD Cash + Short-term Investments

Total Assets

Rs1.61 Billion

≈ $17.38 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Bafna Pharmaceuticals Limited (2018–2024)

Asset resilience ratio of Bafna Pharmaceuticals Limited from 2018 to 2024. This chart shows how Bafna Pharmaceuticals Limited's Asset Resilience Ratio has changed over time. Read debt load of Bafna Pharmaceuticals Limited for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Bafna Pharmaceuticals Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see BAFNAPH asset base.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs17.13 Million	1.07%
Total Liquid Assets	Rs17.13 Million	1.07%

Asset Resilience Insights

Limited Liquidity: Bafna Pharmaceuticals Limited maintains only 1.07% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Bafna Pharmaceuticals Limited Industry Peers by Asset Resilience Ratio

Compare Bafna Pharmaceuticals Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Ajanta Pharma Limited NSE:AJANTPHARM	Drug Manufacturers - Specialty & Generic	14.99%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Jiangsu Nhwa Pharmaceutical Co Ltd SHE:002262	Drug Manufacturers - Specialty & Generic	26.45%
Porton Fine Chemicals Ltd SHE:300363	Drug Manufacturers - Specialty & Generic	6.85%
Jubilant Pharmova Limited NSE:JUBLPHARMA	Drug Manufacturers - Specialty & Generic	1.26%

Bafna Pharmaceuticals Limited Asset Resilience Ratio by Year (2018–2024)

Bafna Pharmaceuticals Limited asset resilience ratio by year from 2018 to 2024. The table below shows the annual Asset Resilience Ratio data for Bafna Pharmaceuticals Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-03-31	0.47%	Rs6.99 Million ≈ $75.63K	Rs1.48 Billion ≈ $15.97 Million	-0.75pp
2021-03-31	1.22%	Rs10.56 Million ≈ $114.21K	Rs864.66 Million ≈ $9.35 Million	-0.93pp
2019-03-31	2.15%	Rs25.74 Million ≈ $278.34K	Rs1.19 Billion ≈ $12.92 Million	+0.38pp
2018-03-31	1.77%	Rs24.50 Million ≈ $264.97K	Rs1.38 Billion ≈ $14.96 Million	--

pp = percentage points

About Bafna Pharmaceuticals Limited

NSE:BAFNAPH India Drug Manufacturers - Specialty & Generic

Market Cap

$116.28 Million

Rs10.75 Billion INR

Market Cap Rank

#18377 Global

#992 in India

Share Price

Rs454.50

Change (1 day)

+1.55%

52-Week Range

Rs99.16 - Rs470.55

All Time High

Rs507.50